Your browser doesn't support javascript.
loading
Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe.
Javed, Muhammad Ahsan; Beyer, Georg; Le, Nha; Vinci, Alessio; Wong, Helen; Palmer, Daniel; Morgan, Robert D; Lamarca, Angela; Hubner, Richard A; Valle, Juan W; Alam, Salma; Chowdhury, Sumsur; Ma, Yuk Ting; Archibugi, Livia; Capurso, Gabriele; Maisonneuve, Patrick; Neesse, Albrecht; Sund, Malin; Schober, Marvin; Krug, Sebastian.
Afiliação
  • Javed MA; NIHR Liverpool Pancreas Biomedical Research Unit, Institute of Translational Medicine, Royal Liverpool University Hospital, United Kingdom.
  • Beyer G; Department of Medicine A, University Medicine Greifswald, Greifswald, Germany; Medical Department II, University Hospital, LMU, Munich, Germany.
  • Le N; Gastroenterology Division, Second Internal Medicine Department, Semmelweis University, Budapest, Hungary.
  • Vinci A; University of Pavia, Department of Surgery, S. Matteo University Hospital Foundation, Pavia, Italy.
  • Wong H; Department of Quality and Information Intelligence, The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom.
  • Palmer D; Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Morgan RD; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Lamarca A; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Hubner RA; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Valle JW; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom; Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
  • Alam S; Department of Hepatobiliary Oncology, New Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
  • Chowdhury S; Department of Hepatobiliary Oncology, New Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
  • Ma YT; Department of Hepatobiliary Oncology, New Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
  • Archibugi L; Digestive and Liver Disease Unit, S. Andrea Hospital, University Sapienza, Rome, Italy.
  • Capurso G; Digestive and Liver Disease Unit, S. Andrea Hospital, University Sapienza, Rome, Italy.
  • Maisonneuve P; Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy.
  • Neesse A; University Medical Centre Göttingen, Department of Gastroenterology and Gastrointestinal Oncology, Göttingen, Germany.
  • Sund M; University of Umea, Department of Surgical and Perioperative Sciences, Umea, Sweden. Electronic address: malin.sund@surgery.umu.se.
  • Schober M; Department of Gastroenterology and Hepatology, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
  • Krug S; Department of Gastroenterology and Hepatology, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
Pancreatology ; 19(1): 97-104, 2019 Jan.
Article em En | MEDLINE | ID: mdl-30529068

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Pancreatology Assunto da revista: ENDOCRINOLOGIA / GASTROENTEROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Pancreatology Assunto da revista: ENDOCRINOLOGIA / GASTROENTEROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido